Rabies vaccine

Published April 11, 2019

RABIES, resulting from the bite of a rabid animal, usually a dog, is prevalent in low-income populations as these are vulnerable to stray dog bites. Rabies is 100 per cent fatal, yet 100pc preventable if treated in the right manner with quality anti rabies vaccine (ARV).

India and China are the two countries that are mainly producing and exporting this vaccine to developing countries. Due to compliance issues, only one manufacturer is now able to supply ARV to Pakistan from China. Unfortunately, this is leading to a drying up of ARV supplies throughout Pakistan, and this situation will very soon lead to an uncontrollable situation of rabies deaths.

The drug regulation authority allows registration of only World Health Organisation pre-qualified vaccine in Pakistan. On Feb 7, Cadilla Healthcare Ltd announced its WHO pre-qualified ARV VaxiRab. Another manufacturer Serum Institute of India, also announced on Dec 20, 2018, its WHO pre-qualified ARV Vero cell®.

The production capacities of vaccines are limited, which means that demand for such products will far exceed the supply. Products will only go to countries that meet a base minimum retail price (MRP).

There is a dire urgency to secure allocation for WHO prequalified ARVs, hence DRAP should urgently register these products without further delay.

With the WHO pre-qualifications in place, no further documents should be awaited from the manufacturer, and a workable MRP should be granted.

I urge the authorities concerned that registration and import of the above two WHO pre-qualified, life-saving ARVs be approved as soon as possible, so that we may save the unfortunate dog bite victims from the dreaded and fatal disease rabies.

Dr Naseem Salahuddin
Head, Dept of Infectious Diseases
The Indus Hospital Karachi
Karachi

Published in Dawn, April 11th, 2019

Opinion

Editorial

New terror wave
Updated 27 Mar, 2024

New terror wave

The time has come for decisive government action against militancy.
Development costs
27 Mar, 2024

Development costs

A HEFTY escalation of 30pc in the cost of ongoing federal development schemes is one of the many decisions where the...
Aitchison controversy
Updated 27 Mar, 2024

Aitchison controversy

It is hoped that higher authorities realise that politics and nepotism have no place in schools.
Ceasefire, finally
Updated 26 Mar, 2024

Ceasefire, finally

Palestinian lives matter, and a generation of orphaned Gazan children will be looking to the world community to secure justice for them.
Afghan return
26 Mar, 2024

Afghan return

FOLLOWING a controversial first repatriation phase involving ‘illegal’ Afghan refugees last November, the...
Planes and plans
26 Mar, 2024

Planes and plans

FOR the past many years, PIA has been getting little by way of good press, mostly on account of internal...